Alamar Biosciences, Inc. (ALMR)

NASDAQ: ALMR · Real-Time Price · USD

22.00

0.00 (0.00%)

At close: Apr 20, 2026, 4:00 PM EDT

22.03

+0.03 (0.14%)

After-hours: Apr 20, 2026, 6:12 PM EDT

Alamar Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-29.82	-47.07
Depreciation & Amortization	2.76	2.29
Other Amortization	1.29	0.98
Loss (Gain) From Sale of Investments	-0.12	-1.89
Stock-Based Compensation	2.87	0.87
Other Operating Activities	1.98	1.59
Change in Accounts Receivable	-5.5	-5.1
Change in Inventory	-23.78	-8.75
Change in Accounts Payable	-0.57	2.92
Change in Other Net Operating Assets	-2.72	-1.06
Operating Cash Flow	-53.61	-55.21
Capital Expenditures	-5.37	-2.95
Sale (Purchase) of Intangibles	-1.01	-0.44
Investment in Securities	52.56	-50.55
Investing Cash Flow	46.18	-53.93
Long-Term Debt Issued	10	-
Long-Term Debt Repaid	-	-15
Net Debt Issued (Repaid)	10	-15
Issuance of Common Stock	1.49	0.94
Other Financing Activities	-0.66	-
Financing Cash Flow	10.84	113.42
Foreign Exchange Rate Adjustments	-0.17	-0
Net Cash Flow	3.23	4.27
Free Cash Flow	-58.98	-58.16
Free Cash Flow Margin	-79.48%	-231.33%
Free Cash Flow Per Share	-2.11	-2.02
Cash Interest Paid	0.13	2.05
Levered Free Cash Flow	-49.7	-
Unlevered Free Cash Flow	-49.65	-
Change in Working Capital	-32.57	-11.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q